Krystal Biotech (NASDAQ:KRYS) reported robust financial results for the first quarter of 2026, highlighted by continued commercial momentum for VYJUVEK, the first and only redosable gene therapy for dystrophic epidermolysis bullosa.
Pinnacle West Capital (NYSE:PNW) reported a significant financial turnaround for the first quarter of 2026, posting consolidated net income of $32.9 million, or $0.27 per diluted share.
GigaMedia (NASDAQ:GIGM) reported unaudited financial results for the first quarter of 2026, characterized by continued revenue pressure and a focus on strategic capital allocation.
Alexander’s (NYSE:ALX) reported a sharp contraction in its first-quarter financial results for 2026, as the New York City real estate market continues to face a complex valuation and leasing landscape.
Hess Midstream (NYSE:HESM) reported first-quarter 2026 net income of $157.7 million, a slight decrease from the $161.4 million recorded in the prior-year period.
Hubbell (NYSE:HUBB) today announced a definitive agreement to acquire NSI Industries, a leading provider of electrical components and infrastructure solutions, for $3 billion in cash.
ADC Therapeutics (NYSE:ADCT), a commercial-stage biotechnology company specializing in antibody-drug conjugates (ADCs), reported its financial results for the first quarter of 2026.
Neurocrine Biosciences (NASDAQ:NBIX) officially entered the clinical arena for metabolic disorders today, announcing the initiation of a Phase 1 first-in-human study for NBIP-'2118.
Tyson Foods (NYSE:TSN) reported its second-quarter 2026 financial results, characterized by a significant rebound in GAAP profitability and steady top-line growth.
L.B. Foster Company (NASDAQ:FSTR) reported a robust first quarter for 2026, highlighted by a 23.9% year-over-year increase in net sales to $121.1 million.
RLJ Lodging Trust (NYSE:RLJ) delivered a solid start to 2026, reporting first-quarter results that outpaced the prior year across several key performance metrics.
DiamondRock Hospitality Company (NYSE:DRH) announced today the sale of its leasehold interest in the 189-room Courtyard by Marriott New York Manhattan/Fifth Avenue for $33 million.
